Results 221 to 230 of about 23,445 (337)

Orofacial myofunctional and anthropometric characteristics of children with and without microcephaly: a case-control study. [PDF]

open access: yesJ Appl Oral Sci
Medeiros AMC   +9 more
europepmc   +1 more source

Examining the Relationship Between Dysphagia, Eating‐Related Symptoms, and Diet Quality Among Oropharyngeal Cancer Patients During Critical Stages of Cancer Survivorship: The U‐DINE Study

open access: yesHead &Neck, EarlyView.
ABSTRACT Background Diet quality is a modifiable factor impacting treatment outcomes in oropharyngeal cancer (OPC), yet the effect of dysphagia and self‐reported eating‐related symptoms remains unclear. This study examined their associations with diet quality in OPC patients.
Beatrice Manduchi   +8 more
wiley   +1 more source

Sarcopenia Trajectories Predict Survival in Operable Head and Neck Cancer

open access: yesHead &Neck, EarlyView.
ABSTRACT Background Sarcopenia is associated with increased treatment toxicity and survival in head and neck squamous cell cancer (HNSCC). This study evaluates sarcopenia trajectories and their association with overall survival (OS) and disease‐free survival (DFS) in operable HNSCC.
Marco A. Mascarella   +12 more
wiley   +1 more source

Health‐Related Quality of Life in Patients With a Head and Neck Sarcoma: A Mixed‐Methods Study

open access: yesHead &Neck, EarlyView.
ABSTRACT Background Patients with head and neck sarcomas (HNS) face unique health‐related quality of life (HRQoL) challenges due to its disease rarity. This study examined and identified the prevalence of generic‐ and location‐specific HRQoL issues.
E. Koffi   +25 more
wiley   +1 more source

Prophylactic Versus Reactive (PvR) Feeding in Patients Undergoing (Chemo)radiation in Head and Neck Cancers: Results of a Phase III Randomized Controlled Trial

open access: yesHead &Neck, EarlyView.
ABSTRACT Background Optimal feeding strategy (Prophylactic vs. Reactive) during Radiation Therapy (RT) for Head and Neck Cancers (HNC) remains to be established. Methods This phase III trial randomized (1:1) patients of HNC to prophylactic [nasogastric tube (NGT) placed at least 1 day before RT starting] versus reactive arm (NGT when required).
Sarbani Ghosh Laskar   +21 more
wiley   +1 more source

Home - About - Disclaimer - Privacy